US4849222A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Mixtures for treating hypercholesterolemia
Assignee: Procter and Gamble Co
•
Filing: 1987-03-24
•
Granted: 1989-07-18
•
Expires: 2007-03-24
Abstract
Abstract Psyllium gum and polyol polyesters are administered orally to reduce blood cholesterol levels.
Inventors
- 👤 Charles D. Broaddus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 22:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/21; A61K31/215; A61K31/25; A61K36/00; A61K36/18; A61K36/185; A61K36/68; A61P; A61P3/00; A61P3/06; A61P9/00; A61P9/08; A61P9/10
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
40 words
A composition of matter for reducing blood cholesterol levels, comprising: (a) psyllium seed gum or source of psyllium seed gum; and (b) a nonabsorbable, nondigestible polyol polyester at a weight ratio of component (a): component (b) from 3:1 to 1:3.
Claim 2
Dependent Claim
40 words
A composition of matter for reducing blood cholesterol levels, comprising: (a) psyllium seed gum or source of psyllium seed gum; and (b) a nonabsorbable, nondigestible polyol polyester at a weight ratio of component (a): component (b) from 3:1 to 1:3.
Claim 3
Independent Claim
69 words
A method for reducing blood cholesterol in a patient in need of such treatment, by administering to said patient: (a) psyllium seed gum or a source of psyllium seed gum; and (b) a nonabsorbable, nondigestible polyol polyester; or (c) mixtures of (a) and (b); said method comprising oral ingestion of from 1 g to 30 g of component (a) and from 5 g to 50 g of component (b).
Claim 4
Independent Claim
69 words
A method for reducing blood cholesterol in a patient in need of such treatment, by administering to said patient: (a) psyllium seed gum or a source of psyllium seed gum; and (b) a nonabsorbable, nondigestible polyol polyester; or (c) mixtures of (a) and (b); said method comprising oral ingestion of from 1 g to 30 g of component (a) and from 5 g to 50 g of component (b).
Claim 5
Dependent Claim
10 words
A method according to claim 2 which comprises chronic ingestion.
Claim 6
Dependent Claim
10 words
A method according to claim 3 which comprises daily ingestion.
Claim 7
Dependent Claim
46 words
A method according to claim 4 which comprises daily ingestion of from about 5 g to about 15 g of component (a) and from about 15 g to about 50 g of component (b), said ingestion being at two or three regularly-spaced intervals throughout the day.
References Cited (Backward Citations)
US2831854A
Cited
US3455714A
Cited
US3600186A
Cited
US3579548A
Cited
US3954976A
Cited
US3963699A
Cited
US4034083A
Cited
US4005196A
Cited
US4005195A
Cited
US4241054A
Cited
US4264583A
Cited
US4382924A
Cited
US4386213A
Cited
US4321263A
Cited
US4461782A
Cited
US4517360A
Cited
US4518772A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-17 | 1993-01-16 | 1993-07-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-17 | 1997-01-16 | 1997-07-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-17 | 2001-01-16 | 2001-07-18 | $7700.00 | Window Closed / Lapsed |